Applying the Promising Zone Method to Biomarker‐Based Adaptive Designs: A Word of Caution
It is shown that the promising zone method can produce Type I error inflation when embedded in biomarker‐based adaptive designs, with the magnitude of inflation depending on the underlying true treatment effect in the biomarker‐positive subgroup and specific design parameters such as the biomarker subgroup prevalence,...